• Isoprinosine (Inosine Pranobex): Mechanistic Innovation a...

  2025-10-22

  This thought-leadership article delivers a deep dive into the mechanistic and translational frontiers of Isoprinosine (inosine pranobex) as an immunomodulatory agent for viral infections. By contextualizing Isoprinosine’s dual action—immune enhancement and direct viral inhibition—within emerging herpesvirus biology and the competitive immunotherapy landscape, we provide actionable strategic guidance for translational researchers seeking to bridge bench and bedside in antiviral immunotherapy.

• STING Pathway Activation and B Cell Modulation: Transform...

  2025-10-21

  This thought-leadership article explores how precise activation of the STING pathway through small molecule modulators like STING agonist-1 is redefining the experimental and therapeutic landscape of immunology, oncology, and inflammation research. Drawing upon mechanistic insights from recent studies in esophageal squamous cell carcinoma, the article provides translational researchers with strategic guidance on leveraging STING agonist-1 to dissect B cell-driven antitumor immunity, optimize model systems, and accelerate biomarker discovery. Unlike conventional product literature, this narrative synthesizes cutting-edge evidence, competitive context, and visionary outlook to chart new directions for translational research.

77 records 6/6 page Previous First page 上5页 6